Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Medical Devices

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > Great themes in news release - beautiful

<< Previous

Bullboard Posts

Next >>

Comment by GekkoInvestor19on May 11, 2020 9:48am

72 Views

Post# 31011293

RE:RE:RE:RE:RE:RE:RE:Great themes in news release - beautiful

The only positive news are the sources Chad's refers to in his quote. Both from Pluristem and Mesoblast - our direct competition who are showing great success while were holding the bag. The irony.

“As a registered respiratory therapist, I have been treating lung disease and acute respiratory distress syndrome (ARDS) for many years. Stem cells seem to be very well tolerated in treating COVID-19,2,3” said Mr. Green.

https://www.biospace.com/article/mesoblast-ltd-s-stem-cell-therapy-shows-83-percent-survival-in-covid-19-patients/

https://www.biospace.com/article/pluristem-advances-placental-cells-to-modulate-covid-19-cytokine-storm-/

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season